Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

IVUS Intravascular Ultrasound ACC

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 

GE HealthCare recalling nuclear imaging systems as FDA warns of dangerous consequences

The FDA alerted patients and providers about the issue Feb. 15, labeling it as the agency’s “most serious” type of recall. 

healthcare value value-based care money dollar

CMS testing 3 new ways to lower drug prices

“HHS is using every tool available to us to lower healthcare costs and increase access to high-quality, affordable healthcare,” says HHS Secretary Xavier Becerra.

Neha Patel doesn’t want her radiologist husband prosecuted for attempted vehicular homicide

The radiologist suspected of trying to murder his wife and children by deliberately driving the family car over a 250-foot cliff has an unlikely ally in his corner.

Thumbnail

Florida cardiology practice, 10 cardiologists pay $2M to settle fraud allegations

The practice and many of its cardiologists allegedly submitted false claims to Medicare, Medicaid, TRICARE and the Federal Employee Health Benefits Program. 

insurance payer payment insurer

Radiologists among 100-plus physician groups urging CMS to take swift action on prior authorization

The American Society of Neuroradiology and Society of Interventional Radiology want the agency to bust what they say is a burdensome barrier to imaging and other crucial aspects of U.S. medicine.

FDA calls out weight loss pills for ‘hidden’ ingredient that puts health of heart patients at risk Alfia Weight Loss Capsules

FDA calls out weight loss pills for ‘hidden’ ingredient that puts health of heart patients at risk

The agency’s own analysis confirmed that these capsules contain sibutramine, which was removed from the market back in 2010 due to safety concerns

HHS issues guidance as COVID-19 PHE winds down

The guidance clarifies what will and will not be impacted by the sunset of the PHE on May 11.